1

COST-EFFECTIVENESS MODEL OF PROSTATE-SPECIFIC ANTIGEN (PSA) SCREENING FOR PROSTATE CANCER

Year:
2001
Language:
english
File:
PDF, 999 KB
english, 2001
11

PCN14 COST-EFFECTIVENESS OFTAXANES AS SECOND LINE AGENTS IN TREATMENT OF METASTATIC BREAST CANCER

Year:
2006
Language:
english
File:
PDF, 48 KB
english, 2006
12

PCV21 COST-EFFECTIVENESS OF THE FIBRATES IN THE REDUCTION OF CORONARY HEART DISEASE EVENTS

Year:
2002
Language:
english
File:
PDF, 61 KB
english, 2002
15

Cost-Effectiveness Analysis Of Lurasidone And Olanzapine In The Treatment Of Schizophrenia

Year:
2016
Language:
english
File:
PDF, 88 KB
english, 2016
22

PAR11 COST-EFFECTIVENESS ANALYSIS FOR TREATMENTS IN ANKYLOSING SPONDYLITIS

Year:
2006
Language:
english
File:
PDF, 65 KB
english, 2006
25

Cost-Effectiveness Analysis of Regorafenib in Patients with Advanced Hepatocellular Carcinoma

Year:
2018
Language:
english
File:
PDF, 76 KB
english, 2018
27

PMT25: COMPARATIVE ECONOMETRIC MODELS OF MEDICAL COSTS

Year:
2000
Language:
english
File:
PDF, 59 KB
english, 2000
33

PIH15 ADJUSTING FORTRIAL QUALITY IN A META-ANALYSIS

Year:
2007
Language:
english
File:
PDF, 71 KB
english, 2007
45

PCN8 THE COST-EFFECTIVENESS OF PROSTATE-SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER DETECTION

Year:
2005
Language:
english
File:
PDF, 69 KB
english, 2005
49

PHM2 ECONOMIC AND QUALITY OF LIFE BURDEN OF HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA

Year:
2006
Language:
english
File:
PDF, 48 KB
english, 2006